Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration today granted marketing authorization for the InBios International ZIKV Detect 2.0 IgM Capture ELISA — the first diagnostic test for detecting Zika virus immunoglobulin (IgM) antibodies that the agency has allowed to be marketed in the US.

The test identifies protein antibodies produced by the body's immune system in response to Zika virus infection in the blood.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.